Renal hyperparathyroidism (rHPT) develops during the early stages of renal failure with high risks of bone fractures, CVD, and death [13,14]. PTH and FGF-23 increase as kidney function declines, and when patients reach kidney failure, they fail to exert their phosphaturic effects. This evidence concerns the gene FGF23 and acute kidney injury.